AVI BioPharma Inc. (AVII) Stock Quote

Detailed Quote for AVI BioPharma Inc. (AVII) 
$ 1.11 R     -0.09 (-7.50%) Volume: 1.18 m 4:00 PM EST Feb 10, 2012
After Hours:  $ 1.08   -0.03 (-2.70%) Volume: 900  4:00 PM EST Feb 10, 2012
Today 5d 1m 3m 1y more
Last Price
1.11
Change $
0.09
Change %
7.50%
Tick
N/A
Bid
N/A
Bid Size
0
Ask
N/A
Ask Size
0
Open
1.19
High
1.19
Low
1.00
Prev Close
1.20
Last Trade
2/10/12
Volume
1.18 m
52 Wk Hi
2.17
52 Wk Low
0.5026
Market Cap
150.67 m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
135,743,120
EPS (TTM)
-0.07
PE Ratio
N/A
Exchange
NSD
News and Media for AVI BioPharma Inc.  (AVII) 
Sector News | Topic News
News for AVII
Thu, Feb 09, 2012
8:30 AM Results From Phase I Clinical Trials Demonstrate Positive Safety Data of AVI BioPharma's RNA-Based Therapeutics for Treatment of Ebola and Marburg Viruses - Marketwire
Thu, Feb 02, 2012
8:30 AM AVI BioPharma to Present Company Overview at the 14th Annual BIO CEO & Investor Conference - Marketwire
Wed, Jan 04, 2012
9:00 AM AVI BioPharma Data Safety Monitoring Board Reports No Safety Concerns Identified in Phase IIb DMD Clinical Trial, Recommends Continuation of Trial - Marketwire
Wed, Dec 14, 2011
5:10 PM AVI BioPharma Receives NASDAQ Notice of Minimum Bid Price Non-Compliance - Marketwire
Fri, Dec 09, 2011
9:00 AM AVI BioPharma Names Jayant Aphale, Ph.D., Senior Vice President of Technical Operations - Marketwire
Tue, Nov 22, 2011
5:00 PM AVI BioPharma to Present Company Overview at the Piper Jaffray Health Care Conference - Marketwire
Tue, Nov 15, 2011
8:00 AM AVI Enters Into Collaborations for the Development of Two Additional Exon-Skipping Products for Duchenne Muscular Dystrophy (DMD) - Marketwire
Tue, Nov 08, 2011
8:01 AM AVI BioPharma to Present Company Overview at the Lazard Capital Markets 8th Annual Healthcare Conference - Marketwire
Thu, Nov 03, 2011
4:05 PM AVI BioPharma Announces Third Quarter 2011 Financial Results and Recent Corporate Developments - Marketwire
Wed, Oct 26, 2011
8:00 AM AVI BioPharma Announces Third Quarter 2011 Financial Results and Corporate Update Conference Call - Marketwire
Fri, Oct 21, 2011
8:16 AM Volatility Grows in Biotech Sector -- Keryx and AVI BioPharma Need to Put Up Results - Marketwire
8:00 AM AVI BioPharma's RNA-Based Therapeutics for Treatment of Ebola and Marburg Viruses Show Positive Safety Data in First Five of Six Cohorts of Phase 1 Clinical Studies - Marketwire
Tue, Oct 18, 2011
8:00 AM AVI BioPharma Announces Data Presentation for RNA-Based Duchenne Muscular Dystrophy Drug Candidate at the 16th International World Muscle Society Congress - Marketwire
Mon, Sep 19, 2011
8:00 AM AVI BioPharma Announces Presentations at 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting - Marketwire
Wed, Sep 14, 2011
8:00 AM AVI BioPharma to Present Company Overview at the UBS Global Life Sciences Conference - Marketwire
Tue, Sep 06, 2011
8:16 AM AEterna Zentaris and AVI BioPharma Maintain Steady Pipelines - Marketwire
Thu, Sep 01, 2011
8:00 AM AVI BioPharma to Present Company Overview at the Stifel Nicolaus 2011 Healthcare Conference - Marketwire
Mon, Aug 15, 2011
4:05 PM AVI BioPharma Initiates Dosing in Phase 2 Study of Eteplirsen in Duchenne Muscular Dystrophy Patients - Marketwire
Wed, Aug 10, 2011
8:00 AM AVI BioPharma to Present Company Overview at the Wedbush Securities Life Science Conference - Marketwire
Thu, Aug 04, 2011
4:00 PM AVI BioPharma Announces Second Quarter 2011 Financial Results and Recent Corporate Developments - Marketwire
More News for AVII >>

Tags for AVI BioPharma Inc.

Research stocks or mutual funds related to AVI BioPharma Inc. by keywords or tags. Find companies that have a similar focus to AVII. The keywords below have been associated to AVII by either user submission or electronic means.

healthcare jobs biotech research clinical trial logistics jobs in memphis fashion employment corporate governance quotient clinical research trial biopharma clinical research software biotech news biotechnology industry news clinical trials data pharmaceutical validation medical device register biotechnology news corporate governance blog pharmaceutical market corporate governance consulting corporate governance training generic pharmaceutical global medical tourism jobs gene pressler clinical diagnostics clinical pharmacology medical devices market medical device pr clinical research consulting gene pitney medical product development bookkeeping jobs nursing jobs medical device sales securities attorney pharmaceutical research and development corporate governance legislation annual report corporate governance committee charter attorney jobs attorney jobs in texas medical device contract manufacturing investment shares corporate governance calpers corporate governance gene tierney pharma manufacturing pharmaceutical clinical research corporate governance practices identity audit pfizer pharmaceutical company

 

NYE - Equity | NYE - ETF | AMX - Equity | AMX - ETF | NSD - Equity | NSD - ETF
NMF - ETF | NMF - Money Market Fund | NMF - Mutual Fund | OTC - Equity | OTO - Equity | OTO - ETF | OTO - Mutual Fund
CNQ - Equity | CBO - Equity | BDM - Equity | TSX - Equity | TSX - ETF | TSX - Mutual Fund | TSV - Equity | TSV - Mutual Fund

Dow Jones Composite Index | Dow Jones Industrial Avg | Dow Jones Transportation Avg | Dow Jones Utiliy Index | NASDAQ 100
Russell 1000 | Russell 2000 | Russell 3000 | Russell Microcap | Russell Midcap | S&P 500 | S&P MidCap 400 | S&P/TSX 60 | S&P/TSX MidCap

Recently Added Symbols   Firms   Find Financial Advisors

Advisors by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

RIAs by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tags: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Insiders: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.

Copyright © 2010 InvestorPoint.com All rights reserved.